Mitochondrial disease, a devastating genetic condition passed from mother to child, is set to spark a national debate in the UK as scientists push the boundaries of medical genetics. The condition, which has no cure, causes progressive damage to the body and brain, with symptoms ranging from poor balance and fatigue to organ failure. For 11-year-old Aaron, the disease has already led to a wheelchair, a heart monitor, and an impending kidney transplant.
At Newcastle University, researchers led by Professor Doug Turnbull are developing techniques to prevent mitochondrial disease by creating embryos with genetic material from both parents and a third-party donor. This 'three-parent' approach would introduce genetic changes that pass to future generations, marking a new level of human genetic modification. While gene therapy has been used before, this would be the first time such changes are heritable.
The ethical concerns are clear, but many doctors argue that the chance to prevent life-threatening disease outweighs them. Senior medical figures, including Sir Mark Walport and Sir John Savill, have called on the health secretary to change the law to allow the techniques once they are deemed safe. Currently, offering them would be a criminal offence.
To gauge public opinion before a parliamentary vote, the Human Fertilisation and Embryology Authority (HFEA) is launching a national consultation. The Nuffield Council on Bioethics will also publish a report on the ethics of the procedures. The debate is uniquely centred on Britain, as no other country is known to be so close to offering such treatment; many nations ban the research due to embryo use.
For families like Aaron's, the stakes are high. His mother, Marian, who asked for anonymity, said: 'I don't know what the future holds for my son. We take each day as it comes.' Professor Turnbull, who sees patients who have lost multiple children to the condition, added: 'I wouldn't be driven to do this work if I didn't see the consequences of mitochondrial disease on families.'
